Magnesium for Blood Sugar
Magnesium is a cofactor for the enzymes of glucose metabolism, and deficiency is genuinely common in poorly controlled diabetes — high glucose drives urinary magnesium loss, which in turn worsens insulin resistance, which raises glucose further. That loop is real and it is worth breaking.
Evidence tier 2, with a caveat that changes how you read the trials.
Table of Contents
Why the Pooled Trials Look Disappointing
Amiri and colleagues' 2026 systematic review in BMC Nutrition pooled 15 randomised trials in 1,085 people with diabetes and prediabetes and found oral magnesium supplementation produced no statistically significant change in insulin levels (MD −1.73; 95% CI −3.73 to 0.27; P = 0.09) or HOMA-IR.
Read carelessly, that is a null result and the end of the story. Read properly, it is the predictable consequence of a design problem that affects every nutrient on this page.
Magnesium is a repletion intervention, not a drug. Correcting a deficiency helps the deficient; giving more to someone already replete does nothing. A trial that enrols both groups and reports a single average will report a diluted effect — and the more replete participants it enrols, the smaller that average gets. A null pooled result is therefore consistent both with "magnesium does not work" and with "magnesium works in the people who need it, and most trial participants did not." The pooled number cannot distinguish those, and neither can this page.
Mohammadi and colleagues' 2026 dose-response meta-analysis in Nutrients takes a broader look at cardiometabolic risk factors and is the other reference point worth reading.
Who This Actually Applies To
The people most likely to benefit are the ones most likely to be depleted:
- Poorly controlled diabetes — glycosuria drags magnesium out with the glucose, so the worse the control, the greater the loss.
- Long-term proton-pump inhibitor users — PPIs impair magnesium absorption, and the FDA has warned about hypomagnesaemia with prolonged use.
- Loop and thiazide diuretic users — renal wasting.
- Heavy alcohol use — both poor intake and increased excretion.
Serum magnesium is a poor test for status — less than 1% of body magnesium is in the blood and the level is defended tightly, so it can read normal against a substantially depleted body store. That is an argument for considering the clinical picture rather than for trusting a normal result.
Forms and Dosing
Typical supplemental doses are 200–400 mg of elemental magnesium a day. The form matters mainly for tolerability:
- Glycinate and malate — well absorbed and the least likely to cause diarrhoea; the usual choice for daily repletion.
- Citrate — well absorbed, mildly laxative, inexpensive.
- Oxide — cheap, poorly absorbed, and mostly a laxative. It is what is in most bargain products.
Food sources are worth naming because unlike some entries here, dietary intake genuinely matters: pumpkin seeds, almonds, spinach, black beans and dark chocolate are all substantial contributors.
Cautions
- It lowers blood glucose, and so does your medication. The effects add. With insulin or a sulfonylurea this is a hypoglycemia risk, and dose changes belong with the prescriber — see hypoglycemia awareness and prevention.
- Reduce the dose in kidney impairment. The kidney clears magnesium, and in significant chronic kidney disease supplementation can cause dangerous accumulation. This is the one contraindication that matters.
- It reduces absorption of several drug classes taken at the same time, including tetracycline and quinolone antibiotics, levothyroxine and bisphosphonates. Space doses by several hours.
- Diarrhoea is the dose-limiting effect for most people, and is the signal to switch form or reduce.
- Measure, do not assume. Adding a supplement without measuring means you learn about an interaction from a symptom rather than from a number.
Key Research Papers
Every DOI below was checked against Crossref and the abstract read for support before it was listed.
- Amiri, et al. Oral magnesium supplements and insulin resistance in individuals with diabetes and pre-diabetes: an updated systematic review and meta-analysis. BMC Nutrition, 2026. Fifteen RCTs, 1,085 participants; no significant change in insulin or HOMA-IR.
- Mohammadi, et al. Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis. Nutrients, 2026;18(15):2435.